Abstract-For studies on the lysosome-stabilizing effect of
Since it was reported that glucocorticosteroids stabilize rat liver lysosomes (1), a variety of nonsteroidal anti-inflammatory drugs have been demonstrated to exhibit lyso some-stabilizing effect (25) . Recent experiments have shown that they also prevent ery throcytes from heat-induced hemolysis (6) (7) (8) 
MATERIALS AND METHODS Preparation of lysosome fraction
Wistar-lmamichi male rats, weighing between 250 g and 300 g, were fasted overnight (18 hr), decapitated and exsanguinated. The liver was quickly excised and rinsed in cold 0.25 M sucrose -0.04 M tris acetate buffer, pH 7.4. After weighing, the tissue was homo genized (20 `,,ow/ v) in a Waring blender at top speed for 30 sec, followed by further homo genation twice using a Potter-Elvehjem teflon pestle. The homogenate was centrifuged at 650 x g for 15 min and the resultant supernatant was centriguged at 3,500 x g for 15 min. The sediment was washed once (lysosome fraction).
Incubation of lysosomes with drugs
The lysosome fraction was suspended to give 0. Correlation between the effects of drugs on the increase in the available enzyme activity and the increase in the soluble enzyme activity Table I shows the inhibitory effects of D-glucaro-1, 4-lactone, salicylic acid and phe nylbutazone on the increases in the available and soluble enzyme activities when lyso somes were incubated at 37'C for 40 min after incubation at 0°C for 18 hr with each drug.
The increases in the available as well as soluble enzyme activities were prevented by When freshly prepared lysosomes in 0.25 M sucrose medium were incubated at 37'C, only a low rate of enzyme release from lysosomes was observed despite extended incuba tion times. This result is similar to that obtained by Tanaka et al. (3) . In order to ob tain an accurate quantitative estimation of lysosome-stabilizing activity of drugs, we had to employ conditions under which a much higher rate of enzyme release from lysosomes Fiu. 4. Effect of anti-inflammatory drugs on saponin-induced hemolysis of rat ery throcytes, in vitro. *Hemolysis was completed after incubation for 40 min with phenylbutazone . R at erythrocytes in 0.15 M sodium phosphate buffer, pH 7.4, containing the drug were incubated in the presence of 0.0025% saponin at 24'C.
At definite time intervals aliquots (usually 4 ml) of sample were subjected to determination of percent hemolysis. All drugs were examined at a final con centration of I x 10"3 M. The ordinate represents the percent acceleration of hemolysis calculated as shown in Eq. (2) in the text.
Each value is the mean ± S.E. of six separate experiments.
could be obtained. Such an objective was realized by incubating lysosomes, which had been kept at 0'C for 18 hr, in 0.4 M sucrose medium at 37'C for 40 min. There have been many reports (2) (3) (4) (5) referring to the effect of drugs on increase in the soluble enzyme activity, while that on increase in the available enzyme activity has seldom been investigated. Shibko et a]. (11) reported that an increase in the available enzyme activity was related to the process of lysosome disintegration and was accompanied by the release of enzymes. In this experiment, the ratio of the increase in the soluble enzyme activity to that for the available enzyme activity varied according to the different condi tions under which the lysosomes were treated. However, the release of enzyme from lysosomes was prevented in parallel with the inhibition of the increase in the available enzyme activity by drugs. D-glucaro-1, 4-lactone exhibited concentration-dependent inhibition of enzyme re lease from lysosomes, and was a more effective lysosome-stabilizer than salicylic acid and phenylbutazone over a wide range of concentrations. This lysosome-stabilizing effect of D-glucaro-1, 4-lactone was common to D-glucaric acid derivatives, such as D-glucaro 6, 3-lactone, D-glucaro-1, 4-6, 3-dilactone, mono potassium D-glucaric acid and 2, 5-di 0-acetyl-D-glucaro-1, 4-6, 3-dilactone.
It has been found that D-glucuronolactone is useful in many types of arthritis and associated rheumatic conditions (15) (16) (17) (18) (19) (20) (21) . There is a route in the uronic acid cycle in which D-glucaric acid derivatives are converted from D-glucuronolactone, in living cells. Ac cording to Ishidate (22) , a striking increase in the excretion of D-glucaric acid derivatives was observed in the urine of pregnant women, and patients suffering from gestational foxicosis, liver cirrhosis, diabetes and rheumatoid polyarthritis. Moreover, it was found that D-glucuronolactone and D-glucaric acid derivatives suppress the leakage of circulating dye at the sites of inflammation induced by passive cutaneous anaphylaxis and CaCl2 (9) . The possibility exists that the lysosome-stabilizing effect of D-glucaric acid derivatives may be connected with their anti-inflammatory effects, since lysosomes may play a role in the inflammatory process (23) (24) (25) (26) . Accordingly, it is of interest to speculate on the phy siological and pathological significance of D-glucaric acid derivatives as lysosome-sta bilizers in living cells more than their being members of the uronic acid cycle.
It is well known that many anti-inflammatory drugs stabilize erythrocyte membranes in the case of heat-induced hemolysis as well as lysosome membranes (6) (7) (8) . According to Nakanishi et al. (5), there is a close correlation between the stabilizing effects of anti inflammatory drugs on lysosome membranes and erythrocyte membranes. In addition, it has also been reported that anti-inflammatory drugs have an affinity for lysosome membranes and also for erythrocyte membranes (27) . Furthermore, in the present ex periment, it was found that certain anti-inflammatory drugs labilize erythrocyte mem branes in the case of saponin-induced hemolysis. These results support the suggestion of the presence of interaction* between membranes and lipid soluble drugs and accom * The nature of this interaction may be the insertion of lipid soluble drugs into the lipid mem branes as postulated for steroids by Weissman (28) . 
